Indacaterol
Springer Basel, 2013
121,95 €On orderDelivery: 2-3 weeks
Here is a comprehensive overview of the development of Onbrez Breezhaler, a newly approved once-daily inhaled beta2 agonist for treating COPD. Covers design and pre-clinical pharmacology of the molecule, early clinical development, efficacy studies and more.
- ISBN-13
- 9783034807081
- ISBN-10
- 3034807082
- Publisher
- Springer Basel
- Year
- 2013
- Publication date
- 2013-11-27
- Pages
- 146
- Dimensions
- 244x162x14
- Weight
- 366